Literature DB >> 10759294

Epidemiologic studies of multiple sclerosis: a review.

E Kahana1.   

Abstract

There is evidence for genetic factors in multiple sclerosis (MS). The evidence come from epidemiologic studies, racial predilection, risk in family members (sibs, half sibs, adoptees) and twins studies. MS is not a Mendelian inherited disease; only the susceptibility to the disease is inherited, the risk of MS being also related to an environmental factor. Many candidate genes were screened, and there are four research groups trying to study the whole genome. MS seem to be an oligo- or multigenic disorder with an apparently similar phenotype for the different genes involved.

Entities:  

Mesh:

Year:  2000        PMID: 10759294     DOI: 10.1016/S0753-3322(00)88859-9

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.

Authors:  Terrence F Meehan; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

Review 2.  The hygiene theory harnessing helminths and their ova to treat autoimmunity.

Authors:  Dana Ben-Ami Shor; Michal Harel; Rami Eliakim; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis.

Authors:  Anne Camille La Flamme; Kate Ruddenklau; B Thomas Bäckström
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

4.  Genetic risk variants in African Americans with multiple sclerosis.

Authors:  Noriko Isobe; Pierre-Antoine Gourraud; Hanne F Harbo; Stacy J Caillier; Adam Santaniello; Pouya Khankhanian; Martin Maiers; Stephen Spellman; Nezih Cereb; SooYoung Yang; Marcelo J Pando; Laura Piccio; Anne H Cross; Philip L De Jager; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

5.  Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.

Authors:  R A Williamson; M P Burgoon; G P Owens; O Ghausi; E Leclerc; L Firme; S Carlson; J Corboy; P W Parren; P P Sanna; D H Gilden; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

Review 6.  Helminth Immunomodulation in Autoimmune Disease.

Authors:  Taylor B Smallwood; Paul R Giacomin; Alex Loukas; Jason P Mulvenna; Richard J Clark; John J Miles
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

7.  Homozygosity Haplotype and Whole-Exome Sequencing Analysis to Identify Potentially Functional Rare Variants Involved in Multiple Sclerosis among Sardinian Families.

Authors:  Teresa Fazia; Daria Marzanati; Anna Laura Carotenuto; Ashley Beecham; Athena Hadjixenofontos; Jacob L McCauley; Valeria Saddi; Marialuisa Piras; Luisa Bernardinelli; Davide Gentilini
Journal:  Curr Issues Mol Biol       Date:  2021-10-27       Impact factor: 2.976

8.  Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.

Authors:  Tuna Sahin; Zülküf Bozgeyik; Mehmet Sait Menzilcioglu; Serdal Citil; Mehmet Fatih Erbay
Journal:  Pol J Radiol       Date:  2015-12-17

Review 9.  Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis.

Authors:  Mahmood Moosazadeh; Ravanbakhsh Esmaeili; Mohammad Mehdi Nasehi; Ghasem Abedi; Mahdi Afshari; Fereshteh Farshidi; Motahareh Kheradmand
Journal:  Iran J Neurol       Date:  2017-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.